Ectodermal Dysplasia: Clinical Trials

2 trials for Ectodermal Dysplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 31Completed 1

Follow Ectodermal Dysplasia: new trials by email Literature Review of Ectodermal Dysplasia trials Research Report on Ectodermal Dysplasia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita
PTX-022, Placebo - Pachyonychia Congenita
Phase 2 / Phase 3CompletedPalvella Therapeutics, Inc.732019-04-012024-08-29
Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)
EDI200 - X-Linked Hypohidrotic Ectodermal Dysplasia
Phase 2CompletedEdimer Pharmaceuticals62013-04-012016-01-20

Narrower conditions

Ectodermal Dysplasia 1, Anhidrotic (1)  ·  Pachyonychia Congenita (1)

Broader conditions

Abnormalities, Multiple (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Skin Abnormalities (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Genetic (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Genetic Diseases, X-Linked (1)  ·  Nail Diseases (1)

Interventions

Fc-EDA (1)

Sponsors

Edimer Pharmaceuticals (1)  ·  Palvella Therapeutics, Inc. (1)

Countries

United States (2)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

David Hansen, MD (1)  ·  Joyce Teng, MD (1)  ·  Kenneth Huttner, MD, PhD (1)